Fluctuations of anti‐Xa concentrations during maintenance enoxaparin therapy for neonatal thrombosis

Abstract

Anti-Xa concentrations fluctuate during maintenance enoxaparin therapy, with therapeutic levels being achieved only sporadically in young infants. Despite this, enoxaparin appears efficacious in thrombosis resolution. Further studies on the impact of stringent control of concentrations on outcomes in this population are warranted.